Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
P53 and ERCC1 gene polymorphisms can predict the recurence risk of breast cancer Background: Genetic variations, molecular and histopathological features, age and stage predict the recurrence risk of breast cancer patients. Gene polymorphisms encoding the enzymes involved in transport and metabolism of drugs, DNA repair or drug pharmacodynamics may predict the treatment response or chemotherapy resistence.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.